Governing Board/ICOC of the CIRM

Board Members

Vice-chairs
Duane Roth
Art Torres, J.D.

Patient Advocate
Marcy Feit, RN, MSN
Leeza Gibbons
Sherry Lansing
Francisco J. Prieto, M.D.
Robert A. Quint, M.D., FSCAI
Joan Samuelson, J.D.
David Serrano Sewell, J.D.
Jeff Sheehy
Jonathan Shestack
Oswald Steward, Ph.D.

Executive officer, Commercial Life Science Entity
Michael Goldberg
Stephen Juelsgaard, D.V.M., J.D.

Executive officer, California Research Institute
Bert Lubin, M.D.
Michael A. Friedman, M.D.
Shlomo Melmed, M.D.
Kristiina Vuori, M.D., Ph.D.

Executive officer, California University
Robert Birgeneau, Ph.D
Philip A. Pizzo, M.D.
Carmen A. Puliafito, M.D., M.B.A.

Executive officer, UC with a medical school
David Brenner, M.D.
Susan V. Bryant, Ph.D.
Sam Hawgood, M.B., B.S.
Claire Pomeroy, M.D., M.B.A.
Eugene Washington, M.D., M.Sc.

Members

CIRM Governing Board

Independent Citizens' Oversight Committee (ICOC)

CIRM is governed by 27 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM's mission has guided the organization since it's inception. These board members serve on eleven subcommittees and on the three working groups that provide recommendations to the board regarding CIRM funding, ethical standards and facilities.

See a list of subcommittee members [pdf]
Learn about the working groups
ICOC Bylaws [pdf]

The CIRM board members represent the expertise and passion of the people of california:

Patient Advocates Our patient advocate members keep the agency's focus where it belongs: on the people who need cures for chronic disease and injury. They represent a wide range of diseases including diabetes, neurodegenerative diseases, HIV/AIDS, autism and spinal chord injury.
Biotechnology Industry The biotechnology leaders on our board ensure that our policies and funding draw on California's biotechnology expertise. With these board members guiding agency decisions we have confidence that the industry will be poised to work with CIRM to accelerate the process of getting these new therapies to the patients who need them.
Research Leaders Having leaders in biomedical research on our board provides the agency with scientific expertise needed to direct the agency's funding initiatives. These members head nationally ranked medical schools and research institutes with track records of moving basic research to the clinic.

Spotlights on Disease

Many meetings of the full board include presentations by patients, clinicians and researchers, keeping the board informed about the latest developments by CIRM grantees.